Company profile
LUNAC Therapeutics
Pursuing the discovery of next generation oral anticoagulant therapies with a reduced risk of causing bleeding.
- Industry
- Research
- Employees
- 2
- Headquarters
- Leeds
- Office locations
- 1
LUNAC Therapeutics company summary
LUNAC Therapeutics is a company in the Research industry, headquartered in Leeds. On LinkedIn the company has around 2 employees.
What technology does LUNAC Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About LUNAC Therapeutics
LUNAC Therapeutics is a spin out from the University of Leeds, UK and is pursuing the discovery of next generation oral anticoagulant therapies with a reduced risk of causing bleeding compared to current treatments. The business is founded on IP generated by Professor Helen Philippou (Professor of Translational Medicine in the Faculty of Medicine and Health at the University of Leeds) and Dr Richard Foster (Associate Professor at the University of Leeds), built on a decade of academic research into FXIIa in association with some of the world’s leading supporters of scientific and medical research, including the Wellcome Trust, British Heart Foundation and the UK’s Medical Research Council.
Where is LUNAC Therapeutics located?
LUNAC Therapeutics lists 1 location.
Compare companies similar to LUNAC Therapeutics
More companies in Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
LUNAC Therapeutics lunactherapeutics.com | Research | 2 | - | Leeds |
| Research | 4,823 | 1945 | Pretoria, Gauteng | |
X, The Moonshot Factory x.company | Research | 3,088 | - | Mountain View, CA |
CSIC csic.es | Research | 5,795 | 1939 | Madrid, Comunidad de Madrid |
icddr,b icddrb.org | Research | 3,180 | 1960 | Dhaka , Dhaka |
Abdul Latif Jameel Poverty Action Lab (J-PAL) povertyactionlab.org | Research | 760 | 2003 | Cambridge, MA |
BRIC-National Institute of Immunology nii.res.in | Research | 237 | 1986 | New Delhi, Delhi |
| Research | 181 | - | Wageningen, Gelderland | |
| Research | 171 | 2017 | Bengaluru, Karnataka | |
CIAT alliancebioversityciat.org | Research | 1,343 | 1967 | Cali, Valle del Cauca |
Stockholm Resilience Centre stockholmresilience.org | Research | 191 | 2007 | Stockholm, Stockholm |
Frequently asked questions about LUNAC Therapeutics
What does LUNAC Therapeutics do?
LUNAC Therapeutics is a spin out from the University of Leeds, UK and is pursuing the discovery of next generation oral anticoagulant therapies with a reduced risk of causing bleeding compared to current treatments. The business is founded on IP generated by Professor Helen Philippou (Professor of Translational Medicine in the Faculty of Medicine and Health at the University of Leeds) and Dr Richard Foster (Associate Professor at the University of Leeds), built on a decade of academic research into FXIIa in association with some of the world’s leading supporters of scientific and medical research, including the Wellcome Trust, British Heart Foundation and the UK’s Medical Research Council.
How many employees does LUNAC Therapeutics have?
LUNAC Therapeutics has around 2 employees on LinkedIn.
Where is LUNAC Therapeutics headquartered?
LUNAC Therapeutics is headquartered in Leeds.
Build a lead list from companies like LUNAC Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.